CTNM
Price
$11.94
Change
+$1.08 (+9.94%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
334.26M
39 days until earnings call
INVA
Price
$18.86
Change
+$0.29 (+1.56%)
Updated
Sep 26 closing price
Capitalization
1.19B
32 days until earnings call
Interact to see
Advertisement

CTNM vs INVA

Header iconCTNM vs INVA Comparison
Open Charts CTNM vs INVABanner chart's image
Contineum Therapeutics
Price$11.94
Change+$1.08 (+9.94%)
Volume$4.55K
Capitalization334.26M
Innoviva
Price$18.86
Change+$0.29 (+1.56%)
Volume$513.82K
Capitalization1.19B
CTNM vs INVA Comparison Chart in %
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. INVA commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a StrongBuy and INVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CTNM: $11.92 vs. INVA: $18.86)
Brand notoriety: CTNM and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 45% vs. INVA: 68%
Market capitalization -- CTNM: $334.26M vs. INVA: $1.19B
CTNM [@Biotechnology] is valued at $334.26M. INVA’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileINVA’s FA Score has 1 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • INVA’s FA Score: 1 green, 4 red.
According to our system of comparison, CTNM is a better buy in the long-term than INVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 4 TA indicator(s) are bullish while INVA’s TA Score has 2 bullish TA indicator(s).

  • CTNM’s TA Score: 4 bullish, 4 bearish.
  • INVA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than INVA.

Price Growth

CTNM (@Biotechnology) experienced а -4.64% price change this week, while INVA (@Biotechnology) price change was -1.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CTNM is expected to report earnings on Nov 05, 2025.

INVA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INVA($1.19B) has a higher market cap than CTNM($334M). INVA has higher P/E ratio than CTNM: INVA (33.09) vs CTNM (26.40). INVA YTD gains are higher at: 8.703 vs. CTNM (-18.498). INVA has higher annual earnings (EBITDA): 112M vs. CTNM (-57.1M). INVA has more cash in the bank: 498M vs. CTNM (175M). CTNM has less debt than INVA: CTNM (5.75M) vs INVA (451M). INVA has higher revenues than CTNM: INVA (370M) vs CTNM (0).
CTNMINVACTNM / INVA
Capitalization334M1.19B28%
EBITDA-57.1M112M-51%
Gain YTD-18.4988.703-213%
P/E Ratio26.4033.0980%
Revenue0370M-
Total Cash175M498M35%
Total Debt5.75M451M1%
FUNDAMENTALS RATINGS
INVA: Fundamental Ratings
INVA
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTNMINVA
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
56%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
57%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 10 days ago
67%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 3 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
54%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHIX37.090.47
+1.28%
Hartford Healthcare I
LAVPX16.550.16
+0.98%
Lord Abbett Fundamental Equity P
WGGNX11.860.06
+0.51%
William Blair Global Leaders N
FLSPX15.160.07
+0.46%
Meeder Spectrum Retail
OGLIX106.07N/A
N/A
Invesco Global R6

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and CCCC have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+9.94%
CCCC - CTNM
28%
Poorly correlated
+1.37%
MREO - CTNM
27%
Poorly correlated
+9.89%
VYGR - CTNM
26%
Poorly correlated
+10.27%
PROK - CTNM
26%
Poorly correlated
-4.96%
INVA - CTNM
25%
Poorly correlated
+1.53%
More

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with DSGN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
+1.56%
DSGN - INVA
34%
Loosely correlated
+7.53%
SLNO - INVA
34%
Loosely correlated
+3.57%
CLDX - INVA
33%
Loosely correlated
+3.52%
NRIX - INVA
32%
Poorly correlated
+7.20%
INSM - INVA
32%
Poorly correlated
+1.06%
More